1st Quarter - Report

GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)

Firm
Client
Income
—
Expenses
$1,490,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Government Issues GOV

HR 675 Strengthening Medicare Anti-Fraud Measures Act - provisions relating to HHS OIG debarment authority Congressional education - GSK's Corporate Social Responsibility Report

LobbyistCovered position, as disclosed
JOHN DEL GIORNO —
GARY HEIMBERG —
JOHN HERZOG —
WILLIAM J SCHUYLER —
SARAH J WALSH —
KIMBERLY A WILLIAMS —

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 675 (112th)

Torts TOR

HR 5, S 218 Help Efficient, Accessible, Low-cost, Timely Healthcare Act - provisions relating to various medical malpractice and civil justice reforms

LobbyistCovered position, as disclosed
JOHN DEL GIORNO —
GARY HEIMBERG —
JOHN HERZOG —
WILLIAM J SCHUYLER —
SARAH J WALSH —
KIMBERLY A WILLIAMS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 5 (112th)

Taxation/Internal Revenue Code TAX

HR 942 American Research and Competitiveness Act - reauthorization of research and development tax credit HR 605, S 312 Patients Freedom to Choose Act - provisions relating to reimbursement of OTC drugs under flexible spending and health savings accounts

LobbyistCovered position, as disclosed
JOHN DEL GIORNO —
GARY HEIMBERG —
JOHN HERZOG —
WILLIAM J SCHUYLER —
SARAH J WALSH —
KIMBERLY A WILLIAMS —

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 605 (112th), H.R. 942 (112th)

Copyright/Patent/Trademark CPT

S 23 Patent Reform Act of 2011 - provisions related to supplemental examination, first inventor to file, best mode, and false marking HR 1249 America Invents Act - provisions related to supplemental examination, first inventor to file, best mode, and false marking

LobbyistCovered position, as disclosed
JOHN DEL GIORNO —
GARY HEIMBERG —
JOHN HERZOG —
WILLIAM J SCHUYLER —
SARAH J WALSH —
KIMBERLY A WILLIAMS —

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1249 (112th)

Health Issues HCR

PL 111-148, PL 111-152 Patient Protection and Affordable Care Act - ACA implementation, Independent Payment Advisory Board (IPAB), comparative effectiveness, health information technology, disease prevention/wellness, sunshine and innovation provisions HR 452 Medicare Decisions Accountability Act - repeal of Independent Payment Advisory Board (IPAB) S 668 Health Care Bureaucrats Elimination Act - repeal of Independent Payment Advisory Board (IPAB) S 296 Preserving Access to Life-Saving Medications Act - provisions related to drug access, drug pricing, generics and the FDA S 223 FAA Air Transportation Modernization and Safety Improvement Act - amendments related to Patient Protection and Affordable Care Act S 319 Pharmaceutical Market Access and Drug Safety Act of 2011 - drug safety and importation Access to Appropriate Immunizations for Veterans Act (currently unassigned) - reintroduction of HR 5516 in 112th Congress Federal Food, Drug, and Cosmetic Act (currently unassigned) - section related to FDA and regulation of nicotine replacement therapies Prescription Drug User Fee Act PDUFA-V (currently unassigned) - issues related to reauthorization of the Prescription Drug User Fee Act

LobbyistCovered position, as disclosed
JOHN DEL GIORNO —
GARY HEIMBERG —
JOHN HERZOG —
MARY CATHERINE MANTHO —
WILLIAM J SCHUYLER —
SARAH J WALSH —
KIMBERLY A WILLIAMS —

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5516 (112th), H.R. 452 (112th)

Medicare/Medicaid MMM

PL 111-148, PL 111-152 Patient Protection and Affordable Care Act - Medicare and Medicaid payment, Medicare Part D coverage gap, 340B drug pricing, meaningful use

LobbyistCovered position, as disclosed
JOHN DEL GIORNO —
GARY HEIMBERG —
JOHN HERZOG —
MARY CATHERINE MANTHO —
WILLIAM J SCHUYLER —
SARAH J WALSH —
KIMBERLY A WILLIAMS —

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

HR 1, H Res 92 Fiscal Year 2011 Continuing Resolution - provisions pertaining to Ryan White CARE Act, FDA funding HR 1473 The Department of Defense and Full Year Continuing Appropriations Act - provisions pertaining to Ryan White CARE Act, FDA funding Fiscal Year 2012 Labor-HHS-Education Appropriations (currently unassigned) - FY 2012 HHS Budget Request; proposal relating to Vaccine Section 317 program, Ryan White CARE Act PL 111-148, PL 111-152 Patient Protection and Affordable Care Act - FY 2011 Prevention and Public Health Fund; allocations for Vaccine Section 317 program and smoking cessation programs

LobbyistCovered position, as disclosed
JOHN DEL GIORNO —
GARY HEIMBERG —
JOHN HERZOG —
WILLIAM J SCHUYLER —
SARAH J WALSH —
KIMBERLY A WILLIAMS —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1473 (112th), H.R. 1 (112th), H.Res. 92 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.